Physical activity and risk of cardiovascular disease events: inflammatory and metabolic mechanisms

Mark Hamer1, Emmanuel Stamatakis

  • 1Department of Epidemiology and Public Health, University College London, United Kingdom. m.hamer@ucl.ac.uk

Insights

Engaging in physical activity, even below recommended levels, significantly lowers cardiovascular disease (CVD) risk. Biological factors like inflammation and hypertension partially explain this protective effect.

Area of Science:

  • Cardiovascular Health
  • Exercise Physiology
  • Biomedical Science

Background:

  • Mechanisms linking physical activity to reduced cardiovascular disease (CVD) risk are not fully understood.
  • Investigating the role of inflammatory, hemostatic, metabolic, and hypertensive factors is crucial for understanding CVD prevention.

Purpose of the Study:

  • To determine how inflammatory/hemostatic factors (C-reactive protein, fibrinogen), metabolic factors (adiposity, cholesterol), and hypertension mediate the relationship between physical activity and CVD risk.
  • To quantify the extent of mediation by these biological risk factors.

Main Methods:

  • Utilized data from a nationally representative sample of 7881 individuals.
  • Linked participant data to a CVD hospital admission and mortality database up to September 2006.
  • Analyzed incident CVD events over an average follow-up of 7.2 years.

Main Results:

  • A total of 226 CVD events occurred during follow-up.
  • Physical activity, including levels below current guidelines, was associated with decreased CVD risk.
  • Vigorous activity showed the lowest risk (HR=0.47).
  • Biological risk factors collectively explained 39.4% (moderate activity) and 22.6% (vigorous activity) of the cardioprotective effects.
  • Inflammation and hypertension were the largest contributors to this mediation.

Conclusions:

  • Any level of physical activity is associated with a reduced risk of cardiovascular disease.
  • The cardioprotective benefits of physical activity are partly mediated by biological risk factors, including inflammation and hypertension.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be met...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...